Could an antiviral pill ease long COVID? new trial hopes so.
NCT ID NCT06161688
First seen Apr 03, 2026 · Last updated May 18, 2026 · Updated 5 times
Summary
This study tests whether the antiviral drug ensitrelvir can help people with long COVID by targeting leftover virus in the body. About 40 adults with long COVID symptoms will receive either the drug or a placebo for 10 days. The main goal is to see if the drug improves physical health and reduces symptoms like fatigue and pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UCSF/Zuckerberg San Francisco General Hospital
San Francisco, California, 94110, United States
Conditions
Explore the condition pages connected to this study.